Free shipping on all orders over $ 500

 About 1 result found for searched term "1421783-64-3" (0.121 seconds)

Cat.No.  Name Target
M2749 Olverembatinib dimesylate Src-bcr-Abl
GZD824 dimesylate; HQP1351 dimesylate
Olverembatinib (GZD824) dimesylate is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.